603998 Stock Overview
Researches, develops, produces, and sells pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Hunan Fangsheng Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.00 |
| 52 Week High | CN¥13.09 |
| 52 Week Low | CN¥7.12 |
| Beta | 0.31 |
| 11 Month Change | -2.40% |
| 3 Month Change | 0.37% |
| 1 Year Change | -5.42% |
| 33 Year Change | 84.87% |
| 5 Year Change | 62.96% |
| Change since IPO | 25.07% |
Recent News & Updates
The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet
Jun 06
Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders
Apr 30Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up
Mar 04Recent updates
The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet
Jun 06Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders
Apr 30Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up
Mar 04Shareholder Returns
| 603998 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 7.1% | 1.0% | -1.4% |
| 1Y | -5.4% | -15.1% | -18.4% |
Return vs Industry: 603998 exceeded the CN Pharmaceuticals industry which returned -17.7% over the past year.
Return vs Market: 603998 exceeded the CN Market which returned -19.1% over the past year.
Price Volatility
| 603998 volatility | |
|---|---|
| 603998 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 603998 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603998's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,686 | Xiaoli Zhou | www.fangsheng.com.cn |
Hunan Fangsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for the treatment of orthopedic, cardiovascular and cerebrovascular, anti-infection, pediatric, gynecological, respiratory system, traumatology, and other diseases. The company was founded in 2002 and is based in Changsha, China.
Hunan Fangsheng Pharmaceutical Co., Ltd. Fundamentals Summary
| 603998 fundamental statistics | |
|---|---|
| Market cap | CN¥4.84b |
| Earnings (TTM) | CN¥193.23m |
| Revenue (TTM) | CN¥1.63b |
25.0x
P/E Ratio3.0x
P/S RatioIs 603998 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603998 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.63b |
| Cost of Revenue | CN¥499.01m |
| Gross Profit | CN¥1.13b |
| Other Expenses | CN¥937.90m |
| Earnings | CN¥193.23m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 69.39% |
| Net Profit Margin | 11.85% |
| Debt/Equity Ratio | 43.1% |
How did 603998 perform over the long term?
See historical performance and comparison